Alvotech (ALVO) Total Liabilities (2020 - 2026)
Alvotech's (ALVO) quarterly Total Liabilities came in at $1.8 billion in Q2 2026, up 13.59% on a YoY basis from $1.6 billion in Q2 2025, and up 4.43% quarter-over-quarter from $1.7 billion in Q1 2026.
Analysis
Alvotech (ALVO) Total Liabilities (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Total Liabilities for 7 consecutive years, with $1.8 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Liabilities rose 13.59% year-over-year to $1.8 billion; the trailing twelve-month figure through Jun 2026 stood at $1.8 billion (up 13.59% YoY), and the FY2025 full-year result was $1.8 billion, up 8.41% from the prior year.
- Total Liabilities climbed to $1.8 billion in Q2 2026 per ALVO's latest filing, from $1.7 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $1.9 billion in Q4 2023 and bottomed at $1.1 billion in Q2 2022.
- Historically, Total Liabilities has averaged $1.6 billion across 5 years, with a median of $1.6 billion in 2024.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities surged 89.87% in 2022, then declined 13.2% in 2024.
- Over 5 years, Total Liabilities stood at $1.4 billion in 2022, then surged by 35.16% to $1.9 billion in 2023, then slipped by 13.2% to $1.6 billion in 2024, then advanced by 8.41% to $1.8 billion in 2025, then climbed by 0.42% to $1.8 billion in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $1.8 billion, $1.7 billion, and $1.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 32.10 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 20.78 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 1.99 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 3.74 Bn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 25.60 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 1.78 Bn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 896.90 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 975.61 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 33.31 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | 21.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.78 Bn |
| Mar 31, 2026 | 1.70 Bn |
| Dec 31, 2025 | 1.77 Bn |
| Sep 30, 2025 | 1.63 Bn |
| Jun 30, 2025 | 1.57 Bn |
| Mar 31, 2025 | 1.63 Bn |
| Dec 31, 2024 | 1.63 Bn |
| Sep 30, 2024 | 1.58 Bn |
| Jun 30, 2024 | 1.67 Bn |
| Mar 31, 2024 | 1.72 Bn |
| Dec 31, 2023 | 1.88 Bn |
| Jun 30, 2023 | 1.39 Bn |
| Dec 31, 2022 | 1.39 Bn |
| Jun 30, 2022 | 1.07 Bn |
| Dec 31, 2021 | 733.59 Mn |
| Dec 31, 2020 | 1.34 Bn |